Eli-Lily antibody combo therapy reported 87% effective at preventing hospitalization/death in at risk patients in phase-3 trials. The only deaths were in the control group.
Also assessed that this efficacy applies to covid variants.
FDA has issued EUA for the drug combo.
https://www.foxnews.com/health/eli-l...hs-by-87-study